Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Benzthiazide measurement |
Has measured component |
False |
Benzthiazide |
Inferred relationship |
Some |
|
Benzthiazide measurement |
Component |
True |
Benzthiazide |
Inferred relationship |
Some |
1 |
Benzthiazide 25 mg and triamterene 50 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzthiazide |
Inferred relationship |
Some |
|
Product containing precisely chlortalidone 50 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzthiazide |
Inferred relationship |
Some |
|
Product containing benzthiazide and triamterene (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzthiazide |
Inferred relationship |
Some |
2 |
Product containing benzthiazide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzthiazide |
Inferred relationship |
Some |
1 |
forgiftning med benzothiadiazid |
Causative agent |
False |
Benzthiazide |
Inferred relationship |
Some |
|
Benzthiazide 25 mg and triamterene 50 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Benzthiazide |
Inferred relationship |
Some |
2 |
Benzthiazide 25 mg and triamterene 50 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzthiazide |
Inferred relationship |
Some |
1 |
Benzthiazide 25 mg and triamterene 50 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Benzthiazide |
Inferred relationship |
Some |
1 |
Benzthiazide 25 mg and triamterene 50 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Benzthiazide |
Inferred relationship |
Some |
2 |
Product containing benzthiazide and triamterene in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzthiazide |
Inferred relationship |
Some |
2 |
Benzthiazide and triamterene only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzthiazide |
Inferred relationship |
Some |
2 |
Product containing only benzthiazide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzthiazide |
Inferred relationship |
Some |
1 |
Benzthiazide and triamterene only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzthiazide |
Inferred relationship |
Some |
2 |
Benzthiazide 25 mg and triamterene 50 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Benzthiazide |
Inferred relationship |
Some |
2 |
Benzthiazide 25 mg and triamterene 50 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Benzthiazide |
Inferred relationship |
Some |
2 |